Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 1–12 of 134 articles · Explore study findings
- Explore study findings
Why Amyloid Beta Fibrils Can Have Different Shapes
Amyloid beta is a family of peptides cut from amyloid precursor protein. Some forms can assemble into long fibers, called fibrils, in which many copies of the peptide align. A label such as A4 Amyloid Beta leaves both the sequence and whether the peptide is already assembled unspecified.
A4 Amyloid Beta1 source (2026)
- Explore study findings
What Amyloid Beta Ratios in Blood Can Reveal Before a Scan Changes
The amyloid beta family includes Aβ42 and Aβ40, two products of the same precursor that differ in length. The ratio of those two forms in plasma is a measurement of circulating peptides. An amyloid PET scan, by contrast, measures a tracer signal associated with deposited amyloid in the brain.
A4 Amyloid Beta2 sources (2026)
- Explore study findings
What Donanemab Follow Up Teaches About Targeting Amyloid Beta
Amyloid beta is a family of peptides produced from a larger membrane protein. Some forms build up in deposits called plaques. Donanemab is an antibody that targets a form of amyloid beta in those deposits. It is the intervention in the research described here; amyloid beta is the target.
A4 Amyloid Beta1 source (2025)
- Explore study findings
What a Rare APP Mutation Reveals About Amyloid in Brain Blood Vessels
Amyloid beta is cut from amyloid precursor protein, or APP, so a change in the gene for APP can change the peptide itself. A rare inherited variant called the Flemish mutation changes position 21 in Aβ from alanine to glycine.
A4 Amyloid Beta1 source (2026)
- Explore study findings
What changed on scans of healthy volunteers
ACE-031 is a larger investigational fusion protein that binds myostatin and other signals involved in regulating muscle. An older first-in-human study in healthy postmenopausal volunteers provides a direct look at the body composition changes that first drew attention to the molecule.
ACE-0311 source (2012)
- Explore study findings
Did ACE-031 change muscle fiber type or size?
ACE-031 is a fusion protein built from part of activin receptor type IIB and an antibody Fc region. Its ability to capture several growth regulators led researchers to ask whether it changes the kinds of fibers in a muscle or primarily changes their size.
ACE-0312 sources (2010, 2026)
- Explore study findings
What the Charcot-Marie-Tooth trial learned from the ankle
ACE-083 is a larger engineered protein that combines a form of follistatin with an antibody Fc region. It was investigated for local muscle growth.
ACE-0831 source (2022)
- Explore study findings
What healthy volunteers revealed about a local effect
ACE-083 is a larger follistatin-based fusion protein developed to trap signals in the tissue where it was placed. Its 2018 first-in-human study asked how healthy volunteers tolerated it and whether a selected muscle changed in volume.
ACE-0832 sources (2018, 2022)
- Explore study findings
What mouse models could reveal about contraction
ACE-083 is a larger engineered follistatin fusion protein built to capture several growth-regulating proteins locally. A 2019 animal study asked whether muscle enlargement after ACE-083 came with a change in the force that the same muscle could produce.
ACE-0832 sources (2019, 2022)
- Explore study findings
What a 2026 study revealed about adipotide’s target
Adipotide is an experimental construct with two linked peptide segments. One was designed to recognize a form of a protein called prohibitin-1 at the surface of blood vessels that supply white fat. The other can trigger programmed cell death after entering a cell.
Adipotide2 sources (2011, 2026)
- Explore study findings
Why the adipotide kidney findings mattered
Adipotide is an investigational two-part peptide construct designed to reach white fat blood vessels and trigger programmed cell death there. The older direct studies illustrate why a report on where a peptide is intended to act belongs alongside observations of which organs actually respond.
Adipotide2 sources (2010–2019)
- Explore study findings
What changed when researchers put the peptide cargo in a nanoparticle
Adipotide connects a fat-vessel-targeting segment directly to a segment that triggers cell death. An older mouse experiment compared this linked design with a delivery particle carrying a similar payload and displaying the targeting peptide on its surface.
Adipotide1 source (2013)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
